Live Quote · OTCOPGXHealthcare· Medical - Diagnostics & Research

Optigenex Inc.

$0.00 0.00%(+$0.00)
TickerSpark Score
46/100
Weak
60
Valuation
40
Profitability
60
Growth
20
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPGX research report →

52-Week Range0% of range
Low
$0.00
Current
$0.00
High
$0.04
Company Overviewwww.optigenex.com

About the company

Optigenex Inc. is a company dedicated to producing and distributing products that promote healthy aging and enhance beauty. A core offering is AC-11, a potent, powdered extract sourced from rainforest plants.

CEO
Daniel Zwiren
IPO
2012
HQ
Melissa, TX, US

Price Chart

+0.00% · this period
$0.04$0.02$0.00May 02Oct 31Jun 04
Valuation
Market Cap
$17
P/E
0.00
P/S
0.00
P/B
0.00
EV/EBITDA
-7.53
Div Yield
0.00%
Profitability
Gross Margin
-22.10%
Op Margin
298.48%
Net Margin
-621.88%
ROE
46.25%
ROIC
44.10%
Growth & Income
Revenue
$465.97K · 54.85%
Net Income
$-2,897,760 · 60.61%
EPS
$0.00 · 0.00%
Op Income
$1.39M
FCF YoY
84.44%
Performance & Tape
52W High
$0.04
52W Low
$0.00
50D MA
$0.00
200D MA
$0.01
Beta
8.46
Avg Volume
16

Get TickerSpark's AI analysis on OPGX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · OPGX

Our OPGX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on OPGX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate OPGX report →
Internal Compare

Similar companies

Peers in the same neighborhood.